Impax Asset Management Group plc Reduces Stock Position in Stericycle, Inc. (NASDAQ:SRCL)

Impax Asset Management Group plc reduced its stake in shares of Stericycle, Inc. (NASDAQ:SRCL) by 51.9% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,406,625 shares of the business services provider’s stock after selling 1,518,516 shares during the quarter. Impax Asset Management Group plc owned approximately 1.52% of Stericycle worth $85,196,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of SRCL. Pentwater Capital Management LP purchased a new position in shares of Stericycle during the second quarter valued at approximately $83,010,000. Magnetar Financial LLC bought a new position in Stericycle in the second quarter worth approximately $81,596,000. Millennium Management LLC boosted its stake in shares of Stericycle by 1,057.6% during the 2nd quarter. Millennium Management LLC now owns 1,315,274 shares of the business services provider’s stock worth $76,457,000 after acquiring an additional 1,201,653 shares during the last quarter. Alpine Associates Management Inc. purchased a new stake in shares of Stericycle in the 2nd quarter worth $62,298,000. Finally, Capital Research Global Investors raised its holdings in Stericycle by 11.4% in the 1st quarter. Capital Research Global Investors now owns 6,667,911 shares of the business services provider’s stock worth $351,732,000 after purchasing an additional 679,974 shares during the period. 98.82% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com started coverage on Stericycle in a report on Monday. They set a “hold” rating for the company. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, Stericycle presently has a consensus rating of “Hold” and a consensus target price of $74.00.

Stericycle Stock Performance

NASDAQ SRCL opened at $61.98 on Tuesday. The firm has a market cap of $5.75 billion, a price-to-earnings ratio of 163.11, a price-to-earnings-growth ratio of 3.38 and a beta of 1.10. Stericycle, Inc. has a twelve month low of $37.78 and a twelve month high of $61.99. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 0.55. The business has a 50-day moving average price of $60.82 and a 200-day moving average price of $56.82.

Stericycle Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.